NCT05258123View on ClinicalTrials.gov

Ginkgo Biloba Extract in the Treatment of Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

June 12, 2018

Study Completion Date

August 15, 2018

Conditions
Schizophrenia
Interventions
DRUG

Ginkgo Biloba Extract

Ginkgo biloba extract with 360mg was administered

DRUG

Placebo oral tablet

Placebo with nine tables was administered

Trial Locations (1)

100096

Beijing HuiLongGuan Hospital, Beijing

All Listed Sponsors
lead

Beijing HuiLongGuan Hospital

OTHER

NCT05258123 - Ginkgo Biloba Extract in the Treatment of Schizophrenia | Biotech Hunter | Biotech Hunter